American Bio Medica Corporation (ABMC)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2022 | 2.24 Million USD | 41.68% |
| 2021 | 1.58 Million USD | -15.81% |
| 2020 | 1.87 Million USD | 19.69% |
| 2019 | 1.56 Million USD | 2.68% |
| 2018 | 1.52 Million USD | 17.09% |
| 2017 | 1.3 Million USD | -11.04% |
| 2016 | 1.46 Million USD | -18.36% |
| 2015 | 1.79 Million USD | -17.34% |
| 2014 | 2.17 Million USD | -1.76% |
| 2013 | 2.21 Million USD | 28.29% |
| 2012 | 1.72 Million USD | -8.1% |
| 2011 | 1.87 Million USD | -15.72% |
| 2010 | 2.22 Million USD | 6.2% |
| 2009 | 2.09 Million USD | -8.79% |
| 2008 | 2.29 Million USD | 17.84% |
| 2007 | 1.95 Million USD | 105.15% |
| 2006 | 951 Thousand USD | 49.06% |
| 2005 | 638 Thousand USD | -16.05% |
| 2004 | 760 Thousand USD | 1.2% |
| 2003 | 751 Thousand USD | -12.37% |
| 2002 | 857 Thousand USD | 14.42% |
| 2001 | 749 Thousand USD | 335.47% |
| 2000 | 172 Thousand USD | -6.01% |
| 1999 | 183 Thousand USD | 0.0% |
| 1998 | - USD | 0.0% |
| 1997 | - USD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 Q3 | - USD | 0.0% |
| 2023 Q1 | 175 Thousand USD | -92.19% |
| 2023 Q2 | - USD | -100.0% |
| 2022 FY | 2.24 Million USD | 41.68% |
| 2022 Q1 | 1.48 Million USD | -5.95% |
| 2022 Q2 | 1.53 Million USD | 3.03% |
| 2022 Q3 | 1.61 Million USD | 5.42% |
| 2022 Q4 | 2.24 Million USD | 38.7% |
| 2021 FY | 1.58 Million USD | -15.81% |
| 2021 Q1 | 1.93 Million USD | 2.88% |
| 2021 Q2 | 1.96 Million USD | 1.71% |
| 2021 Q3 | 1.78 Million USD | -9.26% |
| 2021 Q4 | 1.58 Million USD | -11.33% |
| 2020 Q4 | 1.87 Million USD | 7.81% |
| 2020 FY | 1.87 Million USD | 19.69% |
| 2020 Q2 | 1.76 Million USD | 14.57% |
| 2020 Q3 | 1.74 Million USD | -1.53% |
| 2020 Q1 | 1.54 Million USD | -1.59% |
| 2019 Q2 | 1.44 Million USD | -0.07% |
| 2019 FY | 1.56 Million USD | 2.68% |
| 2019 Q1 | 1.44 Million USD | -5.37% |
| 2019 Q4 | 1.56 Million USD | 2.35% |
| 2019 Q3 | 1.53 Million USD | 6.09% |
| 2018 Q1 | 1.43 Million USD | 9.81% |
| 2018 Q3 | 1.59 Million USD | 1.72% |
| 2018 Q2 | 1.56 Million USD | 9.28% |
| 2018 Q4 | 1.52 Million USD | -4.08% |
| 2018 FY | 1.52 Million USD | 17.09% |
| 2017 Q4 | 1.3 Million USD | -7.77% |
| 2017 Q1 | 1.52 Million USD | 4.02% |
| 2017 Q3 | 1.41 Million USD | 0.64% |
| 2017 FY | 1.3 Million USD | -11.04% |
| 2017 Q2 | 1.4 Million USD | -7.86% |
| 2016 Q1 | 1.37 Million USD | -23.26% |
| 2016 Q3 | 1.54 Million USD | 4.55% |
| 2016 Q4 | 1.46 Million USD | -4.8% |
| 2016 FY | 1.46 Million USD | -18.36% |
| 2016 Q2 | 1.47 Million USD | 6.89% |
| 2015 FY | 1.79 Million USD | -17.34% |
| 2015 Q4 | 1.79 Million USD | -7.37% |
| 2015 Q1 | 1.93 Million USD | -11.09% |
| 2015 Q2 | 2.07 Million USD | 7.09% |
| 2015 Q3 | 1.94 Million USD | -6.28% |
| 2014 Q1 | 2.07 Million USD | -6.28% |
| 2014 FY | 2.17 Million USD | -1.76% |
| 2014 Q2 | 1.91 Million USD | -7.81% |
| 2014 Q3 | 2.08 Million USD | 8.79% |
| 2014 Q4 | 2.17 Million USD | 4.52% |
| 2013 FY | 2.21 Million USD | 28.29% |
| 2013 Q1 | 2.52 Million USD | 46.32% |
| 2013 Q2 | 2.9 Million USD | 14.94% |
| 2013 Q3 | 2.15 Million USD | -25.85% |
| 2013 Q4 | 2.21 Million USD | 2.88% |
| 2012 FY | 1.72 Million USD | -8.1% |
| 2012 Q1 | 1.97 Million USD | 5.01% |
| 2012 Q3 | 2 Million USD | 11.3% |
| 2012 Q2 | 1.79 Million USD | -8.83% |
| 2012 Q4 | 1.72 Million USD | -13.75% |
| 2011 Q4 | 1.87 Million USD | -7.9% |
| 2011 FY | 1.87 Million USD | -15.72% |
| 2011 Q3 | 2.03 Million USD | -3.78% |
| 2011 Q2 | 2.11 Million USD | -9.53% |
| 2011 Q1 | 2.34 Million USD | 5.12% |
| 2010 Q2 | 2.27 Million USD | -12.48% |
| 2010 Q3 | 2.5 Million USD | 10.43% |
| 2010 Q1 | 2.59 Million USD | 23.8% |
| 2010 Q4 | 2.22 Million USD | -11.24% |
| 2010 FY | 2.22 Million USD | 6.2% |
| 2009 Q4 | 2.09 Million USD | -14.96% |
| 2009 Q1 | 2.45 Million USD | 6.87% |
| 2009 Q2 | 2.36 Million USD | -3.58% |
| 2009 Q3 | 2.46 Million USD | 4.09% |
| 2009 FY | 2.09 Million USD | -8.79% |
| 2008 FY | 2.29 Million USD | 17.84% |
| 2008 Q3 | 2.3 Million USD | 33.03% |
| 2008 Q1 | 1.92 Million USD | -1.54% |
| 2008 Q4 | 2.29 Million USD | -0.39% |
| 2008 Q2 | 1.73 Million USD | -9.68% |
| 2007 Q2 | 2.01 Million USD | 8.97% |
| 2007 Q4 | 1.95 Million USD | -5.25% |
| 2007 FY | 1.95 Million USD | 105.15% |
| 2007 Q1 | 1.85 Million USD | 94.53% |
| 2007 Q3 | 2.05 Million USD | 2.13% |
| 2006 Q2 | 835 Thousand USD | -14.09% |
| 2006 Q1 | 972 Thousand USD | 52.35% |
| 2006 Q3 | 701 Thousand USD | -16.05% |
| 2006 Q4 | 951 Thousand USD | 35.66% |
| 2006 FY | 951 Thousand USD | 49.06% |
| 2005 Q2 | 918 Thousand USD | 20.47% |
| 2005 FY | 638 Thousand USD | -16.05% |
| 2005 Q4 | 638 Thousand USD | -20.55% |
| 2005 Q1 | 762 Thousand USD | 0.26% |
| 2005 Q3 | 803 Thousand USD | -12.53% |
| 2004 Q2 | 892 Thousand USD | -6.89% |
| 2004 Q1 | 958 Thousand USD | 27.56% |
| 2004 Q3 | 826 Thousand USD | -7.4% |
| 2004 Q4 | 760 Thousand USD | -7.99% |
| 2004 FY | 760 Thousand USD | 1.2% |
| 2003 FY | 751 Thousand USD | -12.37% |
| 2003 Q1 | 885 Thousand USD | 3.27% |
| 2003 Q3 | 784 Thousand USD | -11.31% |
| 2003 Q4 | 751 Thousand USD | -4.21% |
| 2003 Q2 | 884 Thousand USD | -0.11% |
| 2002 FY | 857 Thousand USD | 14.42% |
| 2002 Q2 | 797 Thousand USD | 7.85% |
| 2002 Q4 | 857 Thousand USD | 9.87% |
| 2002 Q1 | 739 Thousand USD | 0.0% |
| 2002 Q3 | 780 Thousand USD | -2.13% |
| 2001 Q2 | 38 Thousand USD | -17.39% |
| 2001 Q3 | 31 Thousand USD | -18.42% |
| 2001 Q1 | 46 Thousand USD | 15.0% |
| 2001 FY | 749 Thousand USD | 335.47% |
| 2000 Q1 | 172 Thousand USD | -7.53% |
| 2000 Q3 | 166 Thousand USD | 277.27% |
| 2000 Q2 | 44 Thousand USD | -74.42% |
| 2000 FY | 172 Thousand USD | -6.01% |
| 2000 Q4 | 40 Thousand USD | -75.9% |
| 1999 Q3 | 184 Thousand USD | 0.55% |
| 1999 Q2 | 183 Thousand USD | 0.0% |
| 1999 Q1 | 183 Thousand USD | 0.0% |
| 1999 FY | 183 Thousand USD | 0.0% |
| 1999 Q4 | 186 Thousand USD | 1.09% |
| 1998 Q4 | - USD | 0.0% |
| 1998 Q3 | - USD | 0.0% |
| 1998 Q2 | - USD | 0.0% |
| 1998 Q1 | - USD | 0.0% |
| 1998 FY | - USD | 0.0% |
| 1997 FY | - USD | 0.0% |
| 1997 Q4 | - USD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Arrayit Corporation | 1.07 Million USD | -107.76% |
| Atlantic International Corp. | 2.93 Million USD | 23.562% |
| Biocept, Inc. | 12.1 Million USD | 81.501% |
| Bioqual, Inc. | 3.58 Million USD | 37.552% |
| CardioGenics Holdings Inc | 72.61 Thousand USD | -2984.805% |
| DermTech, Inc. | 54.39 Million USD | 95.882% |
| Global WholeHealth Partners Corporation | - USD | -Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 471.86 Million USD | 99.525% |
| HTG Molecular Diagnostics, Inc. | 4.83 Million USD | 53.661% |
| iMD Companies, Inc. | 1.12 Million USD | -99.973% |
| IDenta Corp. | 789.14 Thousand USD | -183.851% |
| Interpace Biosciences, Inc. | 11.19 Million USD | 79.986% |
| Integrative Health Technologies, Inc. | - USD | -Infinity% |
| InVitro International | 43.84 Thousand USD | -5008.906% |
| Lumos Diagnostics Holdings Limited | 8.04 Million USD | 72.156% |
| Many Bright Ideas Technologies Inc. | - USD | -Infinity% |
| Medical Imaging Corp. | 3.82 Million USD | 41.452% |
| NovelStem International Corp. | 3.57 Million USD | 37.336% |
| Optigenex Inc. | 8.94 Million USD | 74.946% |
| PharmChem, Inc. | 77.35 Thousand USD | -2795.815% |
| Proteome Sciences plc | 17.15 Million USD | 86.942% |
| Response Genetics, Inc | 6.37 Million USD | 64.852% |
| Rennova Health, Inc. | 15.32 Million USD | 85.388% |
| RushNet, Inc. | 4.82 Million USD | 53.557% |
| ScreenPro Security Inc. | 207.03 Thousand USD | -981.948% |
| Stella Diagnostics Inc. | 6.2 Million USD | 63.875% |
| StageZero Life Sciences Ltd. | 1.8 Million USD | -24.439% |
| Todos Medical Ltd. | 38.34 Million USD | 94.159% |